Independent Gridinsoft analysis
What Gridinsoft observed on tryrosabella.com
A Gridinsoft threat analyst reviewed the site directly and documented the evidence behind this decision.
Current review
Review ID
GMA-20261002203045-95f7567f
- Reviewed
- by Gridinsoft Threat Analyst
- Analyst finding
- Scoped public-page review
- Evidence basis
- First-party site analysis External vendor intelligence: Context only — not used for this decision
Reviewed public content does not substantiate a broad security warning. This decision covers only the explicitly reviewed hosts and pages.
Analyst findings
Review 1 documented observation View evidence
Both hosts show the Rosabella supplement store. The inspected terms, product and refund pages describe subscriptions; the 90-day guarantee covers first purchases, not recurring orders. FDA records a February 13, 2026 recall of certain Rosabella moringa capsule lots. Current inventory, product efficacy and affected lots were not verified; this is separate from website malware.
- Public artifact URL https://tryrosabella.com/
- Public artifact URL https://www.tryrosabella.com/
- Public artifact URL https://tryrosabella.com/policies/terms-of-service
- Public artifact URL https://tryrosabella.com/policies/refund-policy
- Public artifact URL https://tryrosabella.com/products/rosabella-moringa-gummies-sub
- Public artifact URL https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ambrosia-brands-llc-recalls-rosabella-moringa-capsules-because-possible-health-risk
Scope and limitations
- No authenticated session, purchase or complete server audit was performed. Customer cleanup claims and external scan dates are not independently verified beyond the specific checks described.
